trending Market Intelligence /marketintelligence/en/news-insights/trending/tqywpfz8eopk8lhtr7z9ba2 content esgSubNav
In This List

Scythian Biosciences adds board member

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Scythian Biosciences adds board member

Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.

DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.

Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.